Hertrust 440mg Injection

Hertrust 440mg Injection contains Trastuzumab as its active ingredient and is indicated for HER2-positive breast cancer. In patients with HER2-positive breast cancer, cancer cells express high levels of HER2 protein, which promotes rapid tumour growth through signal transduction pathways. This medication is also used to treat metastatic gastric cancer with elevated HER2 protein expression. HER2-positive breast cancers are typically aggressive. The targeted therapy mechanism works by selectively binding HER2 proteins responsible for cancer cell growth, development, and dissemination.

Use effective contraception during treatment and for at least 7 months after the final dose. Hertrust 440mg Injection is not recommended for patients under 18 years of age or those with severe respiratory compromise requiring supplemental oxygen therapy. Inform your physician if you have cardiac disease, dyspnoea, or have received prior cancer treatment. Disclose all medications to your physician before commencing treatment, including over-the-counter medicines, supplements, and herbal preparations.

The Hertrust 440mg Injection is used in the treatment of the following: Advanced and metastatic breast cancer Metastatic gastric cancer

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hertrust 440mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Hertrust 440mg Injection shall either be administered before or after surgery. It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Hertrust 440mg Injection are: Heart Problems Allergic reactions Kidney problems Breathing difficulties Common side effects of Hertrust 440mg Injection are: Fever Visual disturbances Nose bleeds or runny nose Hair loss Dizziness Nail disorders Weight loss Loss of appetite Bruising Dry mouth Liver inflammation Muscle pain Asthma/ lung disorders

It is suggested to inform your doctor if you have a history of allergic reactions to Hertrust 440mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Hertrust 440mg Injection, as it may impact the functioning of the heart.